This further verified that the synergy between oral and local IMQ was based on oral-IMQ-induced IFN-I production by pDCs, which in turn led to the upregulation of TLR7 on cDCs in the TME, thereby sensitizing these immune cells to local IMQ treatment at the tumor site. The gene discussed is TLR7; the disease is neoplasm.